These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23084023)

  • 21. The spontaneous differentiation and chromosome loss in iPSCs of human trisomy 18 syndrome.
    Li T; Zhao H; Han X; Yao J; Zhang L; Guo Y; Shao Z; Jin Y; Lai D
    Cell Death Dis; 2017 Oct; 8(10):e3149. PubMed ID: 29072700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic Cellular Disease Models Reveal Synergistic Interaction of Trisomy 21 and GATA1 Mutations in Hematopoietic Abnormalities.
    Banno K; Omori S; Hirata K; Nawa N; Nakagawa N; Nishimura K; Ohtaka M; Nakanishi M; Sakuma T; Yamamoto T; Toki T; Ito E; Yamamoto T; Kokubu C; Takeda J; Taniguchi H; Arahori H; Wada K; Kitabatake Y; Ozono K
    Cell Rep; 2016 May; 15(6):1228-41. PubMed ID: 27134169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome silencing in vitro reveals trisomy 21 causes cell-autonomous deficits in angiogenesis and early dysregulation in Notch signaling.
    Moon JE; Lawrence JB
    Cell Rep; 2022 Aug; 40(6):111174. PubMed ID: 35947952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methylation changes in Down syndrome derived neural iPSCs uncover co-dysregulation of ZNF and HOX3 families of transcription factors.
    Laan L; Klar J; Sobol M; Hoeber J; Shahsavani M; Kele M; Fatima A; Zakaria M; Annerén G; Falk A; Schuster J; Dahl N
    Clin Epigenetics; 2020 Jan; 12(1):9. PubMed ID: 31915063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of improved human cerebral organoids from single copy DYRK1A knockout induced pluripotent stem cells in trisomy 21: hypothetical solutions for neurodevelopmental models and therapeutic alternatives in down syndrome.
    Çağlayan ES
    Cell Biol Int; 2016 Dec; 40(12):1256-1270. PubMed ID: 27743462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Domains of genome-wide gene expression dysregulation in Down's syndrome.
    Letourneau A; Santoni FA; Bonilla X; Sailani MR; Gonzalez D; Kind J; Chevalier C; Thurman R; Sandstrom RS; Hibaoui Y; Garieri M; Popadin K; Falconnet E; Gagnebin M; Gehrig C; Vannier A; Guipponi M; Farinelli L; Robyr D; Migliavacca E; Borel C; Deutsch S; Feki A; Stamatoyannopoulos JA; Herault Y; van Steensel B; Guigo R; Antonarakis SE
    Nature; 2014 Apr; 508(7496):345-50. PubMed ID: 24740065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered patterning of trisomy 21 interneuron progenitors.
    Giffin-Rao Y; Sheng J; Strand B; Xu K; Huang L; Medo M; Risgaard KA; Dantinne S; Mohan S; Keshan A; Daley RA; Levesque B; Amundson L; Reese R; Sousa AMM; Tao Y; Wang D; Zhang SC; Bhattacharyya A
    Stem Cell Reports; 2022 Jun; 17(6):1366-1379. PubMed ID: 35623352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21.
    Hibaoui Y; Grad I; Letourneau A; Sailani MR; Dahoun S; Santoni FA; Gimelli S; Guipponi M; Pelte MF; Béna F; Antonarakis SE; Feki A
    EMBO Mol Med; 2014 Feb; 6(2):259-77. PubMed ID: 24375627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of Endothelin Receptor B Contributes to Defective B Cell Lymphopoiesis in Trisomy 21 Pluripotent Stem Cells.
    MacLean GA; McEldoon J; Huang J; Allred J; Canver MC; Orkin SH
    Sci Rep; 2018 May; 8(1):8001. PubMed ID: 29789608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of dysregulated microRNAs in lymphocytes from children with Down syndrome.
    Xu Y; Li W; Liu X; Chen H; Tan K; Chen Y; Tu Z; Dai Y
    Gene; 2013 Nov; 530(2):278-86. PubMed ID: 23933415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of integration-free Down syndrome and isogenic euploid human induced pluripotent stem cells.
    Nehra S; Sharma V; Umrani M; Singhal N
    Stem Cell Res; 2023 Mar; 67():103041. PubMed ID: 36764067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.
    Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK
    PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells.
    Maclean GA; Menne TF; Guo G; Sanchez DJ; Park IH; Daley GQ; Orkin SH
    Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17567-72. PubMed ID: 23045682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. iPSCs Offer a New Look at GATA1-Trisomy 21 Cooperation.
    McNulty M; Crispino JD
    Cell Stem Cell; 2016 May; 18(5):563-4. PubMed ID: 27152438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disomic homozygosity in 21-trisomic cells: a mechanism responsible for transient myeloproliferative syndrome.
    Abe K; Kajii T; Niikawa N
    Hum Genet; 1989 Jul; 82(4):313-6. PubMed ID: 2525515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of a novel isogenic trisomy panel in human embryonic stem cells via microcell-mediated chromosome transfer.
    Hiramatsu K; Abe S; Kazuki K; Osaki M; Kajitani N; Yakura Y; Oshimura M; Kazuki Y
    Biochem Biophys Res Commun; 2019 Jan; 508(2):603-607. PubMed ID: 30509488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells.
    Lu HE; Yang YC; Chen SM; Su HL; Huang PC; Tsai MS; Wang TH; Tseng CP; Hwang SM
    Exp Cell Res; 2013 Feb; 319(4):498-505. PubMed ID: 23041301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21.
    Lyle R; Béna F; Gagos S; Gehrig C; Lopez G; Schinzel A; Lespinasse J; Bottani A; Dahoun S; Taine L; Doco-Fenzy M; Cornillet-Lefèbvre P; Pelet A; Lyonnet S; Toutain A; Colleaux L; Horst J; Kennerknecht I; Wakamatsu N; Descartes M; Franklin JC; Florentin-Arar L; Kitsiou S; Aït Yahya-Graison E; Costantine M; Sinet PM; Delabar JM; Antonarakis SE
    Eur J Hum Genet; 2009 Apr; 17(4):454-66. PubMed ID: 19002211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restoration of keratinocytic phenotypes in autonomous trisomy-rescued cells.
    Tanuma-Takahashi A; Inoue M; Kajiwara K; Takagi R; Yamaguchi A; Samura O; Akutsu H; Sago H; Kiyono T; Okamoto A; Umezawa A
    Stem Cell Res Ther; 2021 Aug; 12(1):476. PubMed ID: 34433490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies.
    Korbel JO; Tirosh-Wagner T; Urban AE; Chen XN; Kasowski M; Dai L; Grubert F; Erdman C; Gao MC; Lange K; Sobel EM; Barlow GM; Aylsworth AS; Carpenter NJ; Clark RD; Cohen MY; Doran E; Falik-Zaccai T; Lewin SO; Lott IT; McGillivray BC; Moeschler JB; Pettenati MJ; Pueschel SM; Rao KW; Shaffer LG; Shohat M; Van Riper AJ; Warburton D; Weissman S; Gerstein MB; Snyder M; Korenberg JR
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12031-6. PubMed ID: 19597142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.